This report should not be construed as providing investment advice. It is for educational purposes only. Before making any investment decision, you should always do your own research or consult a investment professional.
While I try to be accurate, I assume no responsibility for any figure in this spreadsheet. Estimates Estimates Estimates
See my website on stocks or see my blog at the following sites. www.spbrunner.com/stocks.html www.spbrunner.blogspot.com/ Q1 2017
Medtronic PLC NYSE: MDT http://www.medtronic.com Fiscal Yr: Apr 31
Year 4/30/05 4/30/06 4/30/07 4/30/08 4/30/09 4/30/10 4/30/11 4/30/12 4/30/13 4/30/14 4/30/15 4/29/16 4/30/17 4/30/18 4/30/19 Value Description #Y Item Currency
Accounting Rules US GAAP US GAAP US GAAP US GAAP US GAAP US GAAP US GAAP US GAAP US GAAP
USD - CDN$ 1.2568 1.1203 1.1068 1.0163 1.1892 1.0044 0.9442 0.9886 1.0073 1.0957 1.2119 1.2549 1.3388 1.3388 1.3388
split
$28,725.0 <-12 mths -0.37%
Revenue* $10,055 $11,292 $12,299 $13,515 $14,599 $15,817 $15,933 $16,184 $16,590 $17,005 $20,261 $28,833 $30,137 $31,751 $33,551 155.34% <-Total Growth 10 Revenue US$
Increase 10.65% 12.31% 8.92% 9.89% 8.02% 8.34% 0.73% 1.58% 2.51% 2.50% 19.15% 42.31% 4.52% 5.36% 5.67% 9.83% <-IRR #YR-> 10 Revenue US$
5 year Running Average $7,754 $8,902 $10,080 $11,250 $12,352 $13,504 $14,433 $15,210 $15,825 $16,306 $17,195 $19,775 $22,565 $25,597 $28,907 12.59% <-IRR #YR-> 5 Revenue US$
Revenue per Share $8.31 $9.78 $10.76 $12.01 $13.04 $14.41 $14.89 $15.60 $16.33 $17.02 $14.25 $20.61 $21.54 $22.70 $23.98 8.31% <-IRR #YR-> 10 5 yr Running Average US$
Increase 10.57% 17.67% 10.06% 11.65% 8.57% 10.51% 3.29% 4.80% 4.65% 4.25% -16.27% 44.61% 4.52% 5.36% 5.67% 6.50% <-IRR #YR-> 5 5 yr Running Average US$
5 year Running Average $6.39 $7.43 $8.53 $9.67 $10.78 $12.00 $13.02 $13.99 $14.86 $15.65 $15.62 $16.76 $17.95 $19.22 $20.62 7.74% <-IRR #YR-> 10 Revenue per Share US$
P/S (Price/Sales) Med 6.12 5.55 4.52 4.31 3.10 2.70 2.45 2.28 2.56 3.20 4.84 3.50 6.72% <-IRR #YR-> 5 Revenue per Share US$
P/S (Price/Sales) Close 6.34 5.10 4.92 4.11 2.45 3.03 2.81 2.45 2.86 3.46 5.22 3.84 3.90 3.70 3.50 8.48% <-IRR #YR-> 10 5 yr Running Average US$
*Net Sales in M US$ P/S Med 10 yr 3.15 5 yr 3.20 23.64% Diff M/C 5.18% <-IRR #YR-> 5 5 yr Running Average US$
-$11,292 $0 $0 $0 $0 $0 $0 $0 $0 $0 $28,833
-$15,933 $0 $0 $0 $0 $28,833
-$8,902 $0 $0 $0 $0 $0 $0 $0 $0 $0 $19,775
-$14,433 $0 $0 $0 $0 $19,775
-$9.78 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $20.61
-$14.89 $0.00 $0.00 $0.00 $0.00 $20.61
-$7.43 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $16.76
-$13.02 $0.00 $0.00 $0.00 $0.00 $16.76
$2.57 <-12 mths 3.63%
EPS Basic $1.49 $2.11 $2.44 $1.97 $1.94 $2.80 $2.87 $3.43 $3.40 $3.06 $2.44 $2.51 18.96% <-Total Growth 10 EPS Basic US$
EPS Diluted* $1.48 $2.09 $2.41 $1.95 $1.93 $2.79 $2.86 $3.41 $3.37 $3.02 $2.41 $2.48 $3.37 $4.07 $4.52 18.66% <-Total Growth 10 EPS Diluted US$
Increase -7.50% 41.22% 15.31% -19.09% -1.03% 44.56% 2.51% 19.23% -1.17% -10.39% -20.20% 2.90% 35.89% 20.77% 11.06% 1.73% <-IRR #YR-> 10 Earnings per Share US$
Earnings Yield 2.8% 4.2% 4.6% 3.9% 6.0% 6.4% 6.8% 8.9% 7.2% 5.1% 3.2% 3.1% 4.0% 4.9% 5.4% -2.81% <-IRR #YR-> 5 Earnings per Share US$
5 year Running Average $1.21 $1.45 $1.78 $1.91 $1.97 $2.23 $2.39 $2.59 $2.87 $3.09 $3.01 $2.94 $2.93 $3.07 $3.37 7.29% <-IRR #YR-> 10 5 yr Running Average US$
10 year Running Average $0.88 $1.04 $1.23 $1.38 $1.53 $1.72 $1.92 $2.18 $2.39 $2.53 $2.62 $2.66 $2.76 $2.97 $3.23 4.23% <-IRR #YR-> 5 5 yr Running Average US$
* Diluted ESP per share P/S 10 yr 0.06 5 yr 0.05
-$1.48 -$2.09 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $2.48
-$2.86 $0.00 $0.00 $0.00 $0.00 $2.48
-$1.21 -$1.45 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $2.94
-$2.39 $0.00 $0.00 $0.00 $0.00 $2.94
Special Dividends $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 <-Median-> 10 Special Dividends US$
Split ' 99 US$
Dividend* $0.34 $0.39 $0.44 $0.50 $0.75 $0.82 $0.90 $0.97 $1.04 $1.12 $1.22 $1.52 $1.72 $1.72 $1.72 289.74% <-Total Growth 10 Dividends US$
Increase 17.24% 14.71% 12.82% 13.64% 50.00% 9.33% 9.76% 7.78% 7.22% 7.69% 8.93% 24.59% 13.16% 0.00% 0.00% Count 27 Years of data US$
Dividends 5 Yr Running $0.26 $0.30 $0.34 $0.39 $0.48 $0.58 $0.68 $0.79 $0.90 $0.97 $1.05 $1.17 $1.32 $1.46 $1.58 291.33% <-Total Growth 10 Dividends 5 Yr Running US$
Yield H/L Price 0.67% 0.72% 0.91% 0.96% 1.85% 2.11% 2.46% 2.73% 2.49% 2.06% 1.77% 2.11% 2.05% 2.08% <-Median-> 10 Yield H/L Price US$
Yield on High Price 0.62% 0.66% 0.81% 0.86% 1.33% 1.78% 2.15% 2.39% 2.18% 1.80% 1.54% 1.91% 1.93% 1.79% <-Median-> 10 Yield on High Price US$
Yield on Low Price 0.72% 0.80% 1.03% 1.09% 3.08% 2.58% 2.88% 3.19% 2.90% 2.40% 2.08% 2.36% 2.18% 2.49% <-Median-> 10 Yield on Low Price US$
Yield on Close Price 0.65% 0.78% 0.83% 1.01% 2.34% 1.88% 2.15% 2.54% 2.23% 1.90% 1.64% 1.92% 2.05% 2.05% 2.05% 1.91% <-Median-> 10 Yield on Close Price US$
Payout Ratio EPS 22.97% 18.66% 18.26% 25.64% 38.86% 29.39% 31.47% 28.45% 30.86% 37.09% 50.62% 61.29% 51.04% 42.26% 38.05% 31.16% <-Median-> 10 DPR EPS US$
DPR EPS 5 Yr Running 21.72% 20.63% 19.26% 20.57% 24.54% 25.96% 28.56% 30.45% 31.20% 31.39% 34.84% 39.96% 45.19% 47.56% 46.88% 29.50% <-Median-> 10 DPR EPS 5 Yr Running US$
Payout Ratio CFPS 14.59% 20.41% 16.88% 16.12% 21.65% 21.78% 25.75% 22.51% 21.64% 22.56% 35.38% 40.75% 30.34% 26.34% 23.15% 22.14% <-Median-> 10 DPR CF US$
DPR CF 5 Yr Running 14.23% 15.62% 15.68% 15.93% 18.04% 19.53% 20.75% 21.72% 22.58% 22.73% 24.97% 27.61% 29.27% 29.99% 29.47% 21.24% <-Median-> 10 DPR CF 5 Yr Running US$
Payout Ratio CFPS WC 14.49% 12.18% 14.68% 16.09% 23.26% 23.14% 20.26% 22.60% 23.06% 23.60% 51.96% 33.72% 30.34% 26.34% 23.15% 23.10% <-Median-> 10 DPR CF WC US$
DPR CF WC 5 Yr Running 14.23% 13.44% 13.57% 14.20% 16.27% 18.04% 19.69% 21.17% 22.39% 22.52% 25.81% 28.77% 30.39% 30.67% 29.83% 20.43% <-Median-> 10 DPR CF WC 5 Yr Running US$
Median Values 5 Yr Med 5 Yr Cl 2.11% 1.92% 5 Yr Med Payout 37.09% 22.56% 23.60% 14.57% <-IRR #YR-> 10 Dividends US$
* Dividends per share 5 Yr Med and Cur. -2.70% 6.74% Last Div Inc ---> $0.380 $0.430 13.2% 11.05% <-IRR #YR-> 5 Dividends US$
-$0.39 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $1.52
-$0.90 $0.00 $0.00 $0.00 $0.00 $1.52
Historical Dividends Historical High Div 2.97% Low Div 0.32% Ave Div 1.65% Med Div 0.72% Close Div 0.78% Historical Dividends US$
High/Ave/Median Values Curr diff Exp. -30.98% 540.57% Cheap 24.61% Cheap 184.70% Cheap 162.22% High/Ave/Median US$
Future Dividend Yield Div Yd 3.01% earning in 5 Years at IRR of 8.0% Div Inc. 46.93% Future Dividend Yield US$
Future Dividend Yield Div Yd 4.43% earning in 10 Years at IRR of 8.0% Div Inc. 115.89% Future Dividend Yield US$
Future Dividend Yield Div Yd 6.50% earning in 15 Years at IRR of 8.0% Div Inc. 217.22% Future Dividend Yield US$
Cost covered if held 5 years 2.93% 2.92% 3.79% 4.74% 5.01% 5.71% 6.28% 8.11% 8.65% 11.99% 13.50% 16.07% 18.63% 17.46% 14.50% 7.20% <-Median-> 10 Paid Median Price US$
Cost covered if held 10 years 27.00% 18.22% 17.18% 13.41% 10.47% 9.40% 9.54% 12.52% 15.58% 15.04% 16.03% 17.09% 21.74% 22.73% 31.53% 14.23% <-Median-> 10 Paid Median Price US$
Cost covered if held 15 years 112.32% 54.12% 64.15% 67.71% 89.12% 68.88% 46.51% 43.83% 33.92% 24.77% 21.12% 20.95% 27.20% 33.23% 31.38% 45.17% <-Median-> 10 Paid Median Price US$
Cost covered if held 20 years 270.79% 130.40% 153.49% 159.79% 197.14% 144.69% 95.23% 88.60% 67.34% 48.07% 153.49% <-Median-> 7 Paid Median Price US$
Cost covered if held 25 years 557.68% 261.72% 303.61% 309.85% 373.08% 409.70% <-Median-> 2 Paid Median Price US$
H/LYield held 5 yrs 0.76% 0.76% 0.98% 1.21% 1.55% 1.61% 1.66% 2.00% 2.01% 2.77% 3.14% 4.16% 4.84% 4.11% 3.16% 1.83% <-Median-> 10 Paid Median Price US$
H/LYield held 10 yrs 4.91% 3.24% 2.98% 2.29% 2.21% 1.83% 1.75% 2.15% 2.52% 2.32% 2.40% 2.80% 3.54% 3.32% 4.25% 2.30% <-Median-> 10 Paid Median Price US$
H/LYield held 15 yrs 18.58% 8.72% 9.98% 10.28% 16.70% 11.84% 7.47% 6.56% 4.76% 3.30% 2.72% 2.95% 3.81% 4.16% 3.56% 7.01% <-Median-> 10 Paid Median Price US$
H/LYield held 20 yrs 44.81% 20.13% 22.00% 21.38% 24.94% 17.62% 12.61% 11.63% 7.87% 5.07% 21.38% <-Median-> 7 Paid Median Price US$
H/LYield held 25 yrs 66.67% 34.00% 39.00% 35.35% 38.31% 50.34% <-Median-> 2 Paid Median Price US$
Special Dividends CDN$ $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 <-Median-> 10 Special Dividends CDN$
Dividends CDN$ $0.43 $0.44 $0.49 $0.51 $0.89 $0.82 $0.85 $0.96 $1.05 $1.23 $1.48 $1.99 $2.25 $2.25 $2.25 355.32% <-Total Growth 10 Dividends CDN$
Increase 7.47% 2.25% 11.46% 4.34% 75.51% -7.65% 3.18% 12.85% 9.24% 17.15% 20.48% 34.55% 13.16% 0.00% 0.00% 16.37% <-IRR #YR-> 10 Dividends CDN$
Dividend Yield 0.65% 0.78% 0.83% 1.01% 2.34% 1.88% 2.15% 2.54% 2.23% 1.90% 1.64% 1.92% 2.05% 2.05% 2.05% 18.54% <-IRR #YR-> 5 Dividends CDN$
Dividends per share in CDN$ funds Yield 5yr Med. 1.92% Curr diff 6.74%
-$0.44 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $1.99
-$0.85 $0.00 $0.00 $0.00 $0.00 $1.99
Future Dividend Yield Div Yd 3.01% earning in 5 Years at IRR of 8.0% Div Inc. 46.93% Future Dividend Yield CDN$
Future Dividend Yield Div Yd 4.43% earning in 10 Years at IRR of 8.0% Div Inc. 115.89% Future Dividend Yield CDN$
Future Dividend Yield Div Yd 6.50% earning in 15 Years at IRR of 8.0% Div Inc. 217.22% Future Dividend Yield CDN$
Close CDN$ $66.23 $55.89 $58.58 $50.23 $38.05 $43.88 $39.52 $37.77 $47.02 $64.45 $90.23 $103.59 $109.82 $109.82 $109.82 6.36% <-IRR #YR-> 10 Stock Price CDN$
5 yr Period ending 04/30/05 04/30/06 04/30/07 04/30/08 04/30/09 04/30/10 04/30/11 04/30/12 04/30/13 04/30/14 04/30/15 04/29/16 04/30/17 04/30/18 04/30/19 21.25% <-IRR #YR-> 5 Stock Price CDN$
5 year IRR Tot. Ret, -2.84% -2.58% -2.70% -5.57% -10.13% -6.75% -5.21% -6.73% 0.56% 13.18% 17.37% 23.48% 7.67% <-IRR #YR-> 10 Price & Div CDN$
As a Canadian, would I have made money on this stock? Looking at 5 year periods to, including Dividends D. per yr 1.31% 2.23% % Tot Ret 17% 9.50% 23.48% <-IRR #YR-> 5 Price & Div CDN$
-$55.89 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $103.59 Dates 04/30/15 Price & Div CDN$
-$39.52 $0.00 $0.00 $0.00 $0.00 $103.59 04/30/15 Price & Div CDN$
-$55.89 $0.49 $0.51 $0.89 $0.82 $0.85 $0.96 $1.05 $1.23 $1.48 $105.58 Cut & paste 04/30/15 Price & Div CDN$
-$39.52 $0.96 $1.05 $1.23 $1.48 $105.58 dates, do 04/30/15 Price & Div CDN$
-$43.88 $0.85 $0.96 $1.05 $1.23 $91.70 04/30/15 Price & Div CDN$
-$38.05 $0.82 $0.85 $0.96 $1.05 $65.68 04/30/14 Price & Div CDN$
-$50.23 $0.89 $0.82 $0.85 $0.96 $48.07 04/30/13 Price & Div CDN$
-$58.58 $0.51 $0.89 $0.82 $0.85 $38.72 04/30/12 Price & Div CDN$
-$55.89 $0.49 $0.51 $0.89 $0.82 $40.37 not copy 04/30/11 Price & Div CDN$
-$66.23 $0.44 $0.49 $0.51 $0.89 $44.70 04/30/10 Price & Div CDN$
$0.43 $0.44 $0.49 $0.51 $38.94 04/30/09 Price & Div CDN$
$0.43 $0.44 $0.49 $50.73 04/30/08 Price & Div CDN$
$0.43 $0.44 $59.07 04/30/07 Price & Div CDN$
$0.43 $56.33 04/30/06 Price & Div CDN$
$66.66 04/30/05 Price & Div CDN$
04/30/04 Price & Div CDN$
04/30/03 Price & Div CDN$
04/30/02 Price & Div CDN$
Graham No. $16.96 $19.54 $22.82 $21.25 $22.43 $28.93 $30.99 $35.58 $37.33 $36.37 $45.06 $45.57 $52.52 $57.72 $60.82 133.15% <-Total Growth 10 Graham Price US$
Price/GP Ratio Med 3.00 2.78 2.13 2.44 1.80 1.34 1.18 1.00 1.12 1.50 1.53 1.58 1.60 1.51 <-Median-> 10 Price/GP Ratio US$
Price/GP Ratio High 3.22 3.05 2.38 2.72 2.52 1.59 1.35 1.14 1.28 1.71 1.76 1.75 1.69 1.73 <-Median-> 10 Price/GP Ratio US$
Price/GP Ratio Low 2.78 2.51 1.88 2.15 1.09 1.10 1.01 0.85 0.96 1.28 1.30 1.42 1.50 1.19 <-Median-> 10 Price/GP Ratio US$
Price/GP Ratio Close 3.11 2.55 2.32 2.33 1.43 1.51 1.35 1.07 1.25 1.62 1.65 1.74 1.60 1.45 1.38 1.56 <-Median-> 10 Price/GP Ratio US$
Prem/Disc Close 210.79% 155.26% 131.94% 132.59% 42.64% 51.03% 35.09% 7.36% 25.05% 61.75% 65.23% 73.69% 59.77% 45.38% 37.96% 56.39% <-Median-> 10 Graham Price US$
Month, Year Dec-04 Dec-05 Dec-06 Dec-07 Dec-08 Dec-09 Dec-10 Dec-11 Dec-12 Dec-13 Dec-14 Dec-15 Dec-16 Dec-17 Dec-18 Month, Year
Price Close $49.67 $57.57 $53.15 $50.27 $31.42 $43.98 $37.09 $38.25 $41.02 $57.39 $72.20 $76.92 $83.91 $83.91 $83.91 33.61% <-Total Growth 10 Stock Price US$
Increase 2.18% 15.90% -7.68% -5.42% -37.50% 39.97% -15.67% 3.13% 7.24% 39.91% 25.81% 6.54% 9.09% 0.00% 0.00% 2.94% <-IRR #YR-> 10 Stock Price US$
P/E 33.56 27.55 22.05 25.78 16.28 15.76 12.97 11.22 14.35 19.00 29.96 31.02 24.90 20.62 18.56 15.71% <-IRR #YR-> 5 Stock Price US$
Trailing P/E 31.04 38.90 25.43 20.86 16.11 22.79 13.29 13.37 12.03 17.03 23.91 31.92 33.83 24.90 20.62 4.31% <-IRR #YR-> 10 Price & Div US$
Median 10, 5 Yrs D. per yr 1.37% 2.34% % Tot Ret 31.76% 12.99% Price Inc 7.24% P/E: 17.64 19.00 18.05% <-IRR #YR-> 5 Price & Div US$
-$57.57 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $76.92
-$37.09 $0.00 $0.00 $0.00 $0.00 $76.92
-$57.57 $0.44 $0.50 $0.75 $0.82 $0.90 $0.97 $1.04 $1.12 $1.22 $78.44
-$37.09 $0.97 $1.04 $1.12 $1.22 $78.44
Month, Year Apr-05 Apr-06 Apr-07 Apr-08 Apr-09 Apr-10 Apr-11 Apr-12 Apr-13 Apr-14 Apr-15 Apr-16 Apr-17 Apr-18 Apr-19 Month, Year
Price Close $52.70 $49.89 $52.93 $49.42 $32.00 $43.69 $41.86 $38.20 $46.68 $58.82 $74.45 $79.15 $83.91 $83.91 $83.91 58.65% <-Total Growth 10 Stock Price US$
Increase 4.88% -5.33% 6.09% -6.63% -35.25% 36.53% -4.19% -8.74% 22.20% 26.01% 26.57% 6.31% 6.01% 0.00% 0.00% 4.72% <-IRR #YR-> 10 Stock Price US$
P/E 35.61 23.87 21.96 25.34 16.58 15.66 14.64 11.20 13.85 19.48 30.89 31.92 24.90 20.62 18.56 13.59% <-IRR #YR-> 5 Stock Price US$
Trailing P/E 32.94 33.71 25.33 20.51 16.41 22.64 15.00 13.36 13.69 17.45 24.65 32.84 33.83 24.90 20.62 6.17% <-IRR #YR-> 10 Price & Div US$
Median 10, 5 Yrs D. per yr 1.45% 2.15% % Tot Ret 23.46% 13.67% Price Inc 22.20% P/E: 18.03 19.48 15.74% <-IRR #YR-> 5 Price & Div US$
-$49.89 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $79.15
-$41.86 $0.00 $0.00 $0.00 $0.00 $79.15
-$49.89 $0.44 $0.50 $0.75 $0.82 $0.90 $0.97 $1.04 $1.12 $1.22 $80.67
-$41.86 $0.97 $1.04 $1.12 $1.22 $80.67
Price Median H/L $50.83 $54.30 $48.59 $51.82 $40.44 $38.90 $36.54 $35.53 $41.81 $54.48 $69.01 $72.15 $83.87 32.89% <-Total Growth 10 Stock Price US$
Increase 5.15% 6.82% -10.52% 6.65% -21.95% -3.82% -6.07% -2.75% 17.66% 30.32% 26.67% 4.55% 16.24% 2.88% <-IRR #YR-> 10 Stock Price US$
P/E 34.34 25.98 20.16 26.57 20.95 13.94 12.77 10.42 12.41 18.04 28.63 29.09 24.89 14.58% <-IRR #YR-> 5 Stock Price US$
Trailing P/E 31.77 36.69 23.25 21.50 20.74 20.15 13.09 12.42 12.26 16.17 22.85 29.94 33.82 4.34% <-IRR #YR-> 10 Price & Div US$
P/E on Run. 5 yr Ave 42.15 37.34 27.36 27.19 20.51 17.41 15.30 13.73 14.56 17.63 22.90 24.56 28.62 17.00% <-IRR #YR-> 5 Price & Div US$
P/E on Run. 10 yr Ave 57.66 52.03 39.50 37.63 26.41 22.61 19.02 16.28 17.50 21.53 26.30 27.09 30.40 25.98 P/E Ratio Historical Median US$
Median 10, 5 Yrs D. per yr 1.45% 2.42% % Tot Ret 33.52% 14.26% Price Inc 17.66% P/E: 19.10 18.04
-$54.30 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $72.15
-$36.54 $0.00 $0.00 $0.00 $0.00 $72.15
-$54.30 $0.44 $0.50 $0.75 $0.82 $0.90 $0.97 $1.04 $1.12 $1.22 $73.67
-$36.54 $0.97 $1.04 $1.12 $1.22 $73.67
High Months Mar 05 Jan 06 Jan 07 Oct 07 Aug 08 Jan 10 Apr 11 Feb 12 Apr 13 Apr 14 Feb 15 Apr 16 Jul 16
Price Hi $54.54 $59.54 $54.30 $57.86 $56.50 $46.03 $41.86 $40.65 $47.72 $62.31 $79.25 $79.78 $88.92 33.99% <-Total Growth 10 Stock Price US$
Increase 3.59% 9.17% -8.80% 6.56% -2.35% -18.53% -9.06% -2.89% 17.39% 30.57% 27.19% 0.67% 11.46% 2.97% <-IRR #YR-> 10 Stock Price US$
P/E 36.85 28.49 22.53 29.67 29.27 16.50 14.64 11.92 14.16 20.63 32.88 32.17 26.39 13.77% <-IRR #YR-> 5 Stock Price US$
Trailing P/E 34.09 40.23 25.98 24.01 28.97 23.85 15.00 14.21 13.99 18.49 26.24 33.10 35.85 31.72 P/E Ratio Historical Median US$
Median 10, 5 Yrs Price Inc 17.39% P/E: 21.58 20.63 51.21 P/E Ratio Historical High US$
-$59.54 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $79.78
-$41.86 $0.00 $0.00 $0.00 $0.00 $79.78
Low Months May 04 Apr 06 Aug 06 Nov 07 Mar 09 May 09 Aug 10 Aug 11 Jun 12 May 13 May 14 Sep 15 May 16
Price Low $47.12 $49.05 $42.87 $45.77 $24.38 $31.76 $31.21 $30.41 $35.89 $46.65 $58.77 $64.52 $78.82 31.54% <-Total Growth 10 Stock Price US$
Increase 7.02% 4.10% -12.60% 6.76% -46.73% 30.27% -1.73% -2.56% 18.02% 29.98% 25.98% 9.78% 22.16% 2.78% <-IRR #YR-> 10 Stock Price US$
P/E 31.84 23.47 17.79 23.47 12.63 11.38 10.91 8.92 10.65 15.45 24.39 26.02 23.39 15.63% <-IRR #YR-> 5 Stock Price US$
Trailing P/E 29.45 33.14 20.51 18.99 12.50 16.46 11.19 10.63 10.52 13.84 19.46 26.77 31.78 20.06 P/E Ratio Historical Median US$
Median 10, 5 Yrs Price Inc 18.02% P/E: 14.04 15.45 12.61 P/E Ratio Historical Low US$
-$49.05 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $64.52
Long Term Debt $33,752 $30,247 $30,124 Debt US$
Ratio to Market Cap 0.32 0.27 0.26 0.30 <-Median-> 2 % of Market C. US$
Goodwill & Intangibles $13,002 $12,879 $68,631 $68,399 $67,746 Intangibles Goodwill US$
Ratio to Market Cap 0.27 0.22 0.65 0.62 0.58 0.45 <-Median-> 4 % of Market C. US$
Market Cap $63,778 $57,623 $60,499 $55,598 $35,817 $47,943 $44,797 $39,621 $47,428 $58,761 $105,842 $110,732 $117,392 $117,392 $117,392 92.17% <-Total Growth 10 Market Cap US$
Diluted 1,220.8 1,217.3 1,161.8 1,143.8 1,126.3 1,109.4 1,081.7 1,059.9 1,027.5 1,013.6 1,109.0 1,425.9 17.14% <-Total Growth 10 Diluted US$
Change -0.42% -0.29% -4.56% -1.55% -1.53% -1.50% -2.50% -2.02% -3.06% -1.35% 9.41% 28.58% -1.54% <-Median-> 10 Change US$
Average # of Sh in M 1,209.8 1,204.5 1,149.7 1,130.7 1,117.8 1,106.3 1,077.4 1,053.9 1,019.3 1,002.1 1,095.5 1,409.6 17.03% <-Total Growth 10 Average US$
Change -0.32% -0.44% -4.55% -1.65% -1.14% -1.03% -2.61% -2.18% -3.28% -1.69% 9.32% 28.67% -1.67% <-Median-> 10 Change US$
Difference 0.0% -4.1% -0.6% -0.5% 0.1% -0.8% -0.7% -1.6% -0.3% -0.3% 29.8% -0.8% -0.54% <-Median-> 10 Difference US$
$5,952 <-12 mths 14.07%
# of Share in Millions 1,210 1,155 1,143 1,125 1,119 1,097 1,070 1,037 1,016 999 1,422 1,399 1,399 1,399 1,399 1.94% <-IRR #YR-> 10 Shares US$
Change 0.07% -4.56% -1.04% -1.57% -0.51% -1.96% -2.48% -3.08% -2.04% -1.67% 42.31% -1.59% 0.00% 0.00% 0.00% 5.51% <-IRR #YR-> 5 Shares US$
CF fr Op $M $2,819 $2,207 $2,979 $3,489 $3,878 $4,131 $3,741 $4,470 $4,883 $4,959 $4,902 $5,218 $7,932 $9,136 $10,395 136.39% <-Total Growth 10 Cash Flow US$
Increase -0.93% -21.71% 34.96% 17.12% 11.15% 6.52% -9.44% 19.49% 9.24% 1.56% -1.15% 6.45% 52.02% 15.17% 13.78% SO Buy Backs Share Issue US$
5 year Running Average $2,233 $2,308 $2,586 $2,868 $3,075 $3,337 $3,644 $3,942 $4,221 $4,437 $4,591 $4,886 $5,579 $6,429 $7,517 111.70% <-Total Growth 10 CF 5 Yr Running US$
CFPS $2.33 $1.91 $2.61 $3.10 $3.46 $3.76 $3.50 $4.31 $4.81 $4.96 $3.45 $3.73 $5.67 $6.53 $7.43 95.16% <-Total Growth 10 Cash Flow per Share US$
Increase -0.99% -17.96% 36.37% 18.99% 11.72% 8.65% -7.14% 23.28% 11.52% 3.29% -30.54% 8.17% 52.02% 15.17% 13.78% 8.98% <-IRR #YR-> 10 Cash Flow US$
5 year Running Average $1.84 $1.92 $2.18 $2.46 $2.68 $2.97 $3.29 $3.63 $3.97 $4.27 $4.20 $4.25 $4.52 $4.87 $5.36 6.88% <-IRR #YR-> 5 Cash Flow US$
P/CF on Med Price 21.82 28.41 18.64 16.71 11.67 10.33 10.45 8.24 8.70 10.98 20.01 19.34 14.79 6.91% <-IRR #YR-> 10 Cash Flow per Share US$
P/CF on Closing Price 22.62 26.10 20.31 15.94 9.24 11.61 11.97 8.86 9.71 11.85 21.59 21.22 14.80 12.85 11.29 1.30% <-IRR #YR-> 5 Cash Flow per Share US$
30.69% Diff M/C 8.27% <-IRR #YR-> 10 CFPS 5 yr Running US$
Excl.Working Capital CF $20.5 $1,489.6 $448.0 $6.0 -$269.0 -$242.0 $1,012.0 -$18.0 -$301.0 -$218.0 -$1,564.0 $1,089.0 $0.0 $0.0 $0.0 5.28% <-IRR #YR-> 5 CFPS 5 yr Running US$
CF fr Op $M WC $2,840 $3,697 $3,427 $3,495 $3,609 $3,889 $4,753 $4,452 $4,582 $4,741 $3,338 $6,307 $7,932 $9,136 $10,395 70.60% <-Total Growth 10 Cash Flow less WC US$
Increase 9.05% 30.18% -7.30% 1.98% 3.26% 7.76% 22.22% -6.33% 2.92% 3.47% -29.59% 88.95% 25.77% 15.17% 13.78% 5.49% <-IRR #YR-> 10 Cash Flow less WC US$
5 year Running Average $2,234 $2,671 $2,977 $3,213 $3,414 $3,623 $3,835 $4,040 $4,257 $4,483 $4,373 $4,684 $5,380 $6,291 $7,422 5.82% <-IRR #YR-> 5 Cash Flow less WC US$
CFPS Excl. WC $2.35 $3.20 $3.00 $3.11 $3.22 $3.54 $4.44 $4.29 $4.51 $4.75 $2.35 $4.51 $5.67 $6.53 $7.43 5.78% <-IRR #YR-> 10 CF less WC 5 Yr Run US$
Increase 8.98% 36.40% -6.33% 3.62% 3.79% 9.91% 25.32% -3.36% 5.07% 5.23% -50.52% 92.00% 25.77% 15.17% 13.78% 4.08% <-IRR #YR-> 5 CF less WC 5 Yr Run US$
5 year Running Average $1.84 $2.23 $2.52 $2.76 $2.98 $3.21 $3.46 $3.72 $4.00 $4.31 $4.07 $4.08 $4.36 $4.76 $5.30 3.48% <-IRR #YR-> 10 CFPS - Less WC US$
P/CF on Med Price 21.66 16.96 16.20 16.68 12.54 10.97 8.23 8.28 9.27 11.48 29.39 16.00 0.30% <-IRR #YR-> 5 CFPS - Less WC US$
P/CF on Closing Price 22.46 15.59 17.65 15.91 9.92 12.33 9.42 8.90 10.35 12.39 31.71 17.56 14.80 12.85 11.29 6.22% <-IRR #YR-> 10 CFPS 5 yr Running US$
*Operational Cash Flow per share CF/-WC P/CF Med 10 yr 11.32 5 yr 10.98 P/CF Med 10 yr 12.01 5 yr 11.48 23.21% Diff M/C 3.34% <-IRR #YR-> 5 CFPS 5 yr Running US$
-$1.91 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $3.73 Cash Flow per Share
-$3.50 $0.00 $0.00 $0.00 $0.00 $3.73 Cash Flow per Share
-$1.92 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $4.25 CFPS 5 yr Running
-$3.29 $0.00 $0.00 $0.00 $0.00 $4.25 CFPS 5 yr Running
-$3,697 $0 $0 $0 $0 $0 $0 $0 $0 $0 $6,307 Cash Flow less WC
-$4,753 $0 $0 $0 $0 $6,307 Cash Flow less WC
-$2,671 $0 $0 $0 $0 $0 $0 $0 $0 $0 $4,684 CF less WC 5 Yr Run
-$3,835 $0 $0 $0 $0 $4,684 CF less WC 5 Yr Run
-$3.20 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $4.51 CFPS - Less WC
-$4.44 $0.00 $0.00 $0.00 $0.00 $4.51 CFPS - Less WC
-$2.23 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $4.08 CFPS 5 yr Running
-$3.46 $0.00 $0.00 $0.00 $0.00 $4.08 CFPS 5 yr Running
OPM 28.04% 19.55% 24.22% 25.82% 26.56% 26.12% 23.48% 27.62% 29.43% 29.16% 24.19% 18.10% -7.42% <-Total Growth 10 OPM US$
Increase -10.46% -30.29% 23.91% 6.58% 2.90% -1.68% -10.10% 17.63% 6.57% -0.92% -17.03% -25.20% Should increase or be stable. US$
Diff from Ave 8.0% -24.7% -6.7% -0.6% 2.3% 0.6% -9.6% 6.4% 13.4% 12.3% -6.8% -30.3% 0.00 <-Median-> 10 OPM US$
*Operational Profit Margin (CF/Revenue) Ratio OPM 10 Yrs 25.97% 5 Yrs 27.62% should be zero, it is a check on calculations US$
Current Assets $7,422 $10,377 $7,918 $7,322 $7,404 $9,839 $9,117 $9,151 $17,793 $21,210 $30,844 $23,600 $23,498 Liquidity ratio of 1.5 and up, best Assets US$
Current Liabilities $3,380 $4,406 $2,563 $3,535 $2,969 $5,121 $4,714 $5,857 $3,891 $5,559 $9,173 $7,165 $7,896 2.79 <-Median-> 10 Liabilities US$
Liquidity 2.20 2.36 3.09 2.07 2.49 1.92 1.93 1.56 4.57 3.82 3.36 3.29 2.98 3.36 <-Median-> 5 Ratio US$
Liq. with CF aft div 2.91 2.75 4.06 2.90 3.52 2.55 2.52 2.15 5.56 4.51 3.71 3.73 3.68 3.73 <-Median-> 5 Ratio US$
Liq. CF re Inv+Div 2.91 2.75 2.44 1.62 1.83 1.32 1.82 1.48 3.09 2.74 1.30 3.73 3.68 2.74 <-Median-> 5 Ratio US$
Assets $16,617 $19,665 $19,512 $22,198 $23,605 $28,090 $30,424 $33,083 $34,841 $37,943 $106,685 $99,782 $98,601 Debt Ratio of 1.5 and up, best Assets US$
Liabilities $6,168 $10,282 $8,535 $10,622 $10,632 $13,461 $14,456 $15,970 $16,170 $18,500 $53,455 $47,719 $47,709 2.09 <-Median-> 10 Liabilities US$
Debt Ratio 2.69 1.91 2.29 2.09 2.22 2.09 2.10 2.07 2.15 2.05 2.00 2.09 2.07 2.07 <-Median-> 5 Ratio US$
Book Value $10,450 $9,383 $10,977 $11,576 $12,973 $14,629 $15,968 $17,113 $18,671 $19,443 $53,230 $52,063 $50,892 $50,892 $50,892 454.89% <-Total Growth 10 Book Value US$
Book Value per Share $8.63 $8.12 $9.60 $10.29 $11.59 $13.33 $14.92 $16.50 $18.38 $19.46 $37.44 $37.21 $36.38 $36.38 $36.38 358.11% <-Total Growth 10 Book Value per Share US$
Change 15.04% -5.92% 18.22% 7.14% 12.64% 15.02% 11.93% 10.58% 11.38% 5.91% 92.38% -0.61% -2.25% 0.00% 0.00% -12.09% P/B Ratio Current/10 Year Median US$
P/B Ratio (Median) 5.89 6.68 5.06 5.04 3.49 2.92 2.45 2.15 2.27 2.80 1.84 1.94 2.31 5.47 P/B Ratio Historical Median US$
P/B Ratio (Close) 6.10 6.14 5.51 4.80 2.76 3.28 2.81 2.32 2.54 3.02 1.99 2.13 2.31 2.31 2.31 16.44% <-IRR #YR-> 10 Book Value per Share US$
Change -8.84% 0.62% -10.26% -12.86% -42.52% 18.70% -14.40% -17.47% 9.71% 18.98% -34.21% 6.97% 8.45% 0.00% 0.00% 20.06% <-IRR #YR-> 5 Book Value per Share US$
Leverage (A/BK) 1.59 2.10 1.78 1.92 1.82 1.92 1.91 1.93 1.87 1.95 2.00 1.92 1.94 1.92 <-Median-> 10 A/BV US$
Debt/Equity Ratio 0.59 1.10 0.78 0.92 0.82 0.92 0.91 0.93 0.87 0.95 1.00 0.92 0.94 0.92 <-Median-> 10 Debt/Eq Ratio US$
Sharerholders Equity (Assets less liabilities) P/BV 10 yr Med 2.62 5 yr Med 2.15 -12.09% Diff M/C 1.74 Historical Leverage (A/BK) US$
-$8.12 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $37.21
-$14.92 $0.00 $0.00 $0.00 $0.00 $37.21
$2,979 <-12 mths 4.38%
Comprehensive Income $3,368 $3,179 $3,448 $2,960 $2,088 $2,854 -15.26% <-Total Growth 5 Comprehensive Income US$
Increase -5.61% 8.46% -14.15% -29.46% 36.69% -5.61% <-Median-> 5 Comprehensive Income US$
5 Yr Running Average $3,009 $2,906 -3.26% <-IRR #YR-> 5 Comprehensive Income US$
ROE 21.1% 18.6% 18.5% 15.2% 3.9% 5.5% -3.26% <-IRR #YR-> 5 Comprehensive Income US$
5Yr Median 18.5% 18.5% 15.2% US$
% Difference from NI 8.8% -12.1% -0.5% -3.4% -21.9% -19.3% US$
Median Values Diff 5, 10 yr -7.8% -12.1% 15.2% <-Median-> 5 Return on Equity US$
-$3,368 $0 $0 $0 $0 $2,854
-$3,368 $0 $0 $0 $0 $2,854
Current Liability Coverage Ratio 0.84 0.84 1.34 0.99 1.22 0.76 1.01 0.76 1.18 0.85 0.36 0.88 CFO / Current Liabilities US$
5 year Median 0.84 0.84 0.84 0.84 0.99 0.99 1.01 0.99 1.01 0.85 0.85 0.85 0.85 <-Median-> 5 Current Liability Cov Ratio US$
Asset Efficiency Ratio 17.09% 18.80% 17.56% 15.74% 15.29% 13.84% 15.62% 13.46% 13.15% 12.50% 3.13% 6.32% CFO / Total Assets US$
5 year Median 18.45% 18.45% 18.45% 17.56% 17.09% 15.74% 15.62% 15.29% 13.84% 13.46% 13.15% 12.50% 12.5% <-Median-> 5 Return on Assets US$
Return on Assets ROA 10.9% 13.0% 14.4% 10.1% 9.2% 11.0% 10.2% 10.9% 10.0% 8.1% 2.5% 3.5% Net Income/Assets Return on Assets US$
5Yr Median 13.0% 13.0% 13.0% 13.0% 10.9% 11.0% 10.2% 10.2% 10.2% 10.2% 10.0% 8.1% 8.1% <-Median-> 5 Asset Efficiency Ratio US$
Return on Equity ROE 17.3% 27.1% 25.5% 19.3% 16.7% 21.2% 19.4% 21.1% 18.6% 15.8% 5.0% 6.8% Net Inc/ Shareholders' equity Return on Equity US$
5Yr Median 19.0% 20.2% 21.6% 21.6% 19.3% 21.2% 19.4% 19.4% 19.4% 19.4% 18.6% 15.8% 15.8% <-Median-> 5 Return on Equity US$
$3,647 <-12 mths 3.08%
Net Income $1,804 $2,547 $2,802 $2,231 $2,169 $3,099 $3,096 $3,617 $3,467 $3,065 $2,675 $3,538 $5,049 $5,923 $6,316 38.92% <-Total Growth 10 Net Income US$
Increase -7.93% 41.18% 10.02% -20.38% -2.78% 42.88% -0.10% 16.83% -4.15% -11.60% -12.72% 32.26% 42.71% 17.31% 6.64% EPS/CF Ratio should not be higher than 1.00 US$
5 Yr Running Average $1,479 $1,779 $2,142 $2,269 $2,311 $2,570 $2,679 $2,842 $3,090 $3,269 $3,184 $3,272 $3,559 $4,050 $4,700 3.34% <-IRR #YR-> 10 Net Income US$
Operating Cash Flow $2,819 $2,207 $2,979 $3,489 $3,878 $4,131 $3,741 $4,470 $4,883 $4,959 $4,902 $5,218 2.70% <-IRR #YR-> 5 Net Income US$
Investment Cash Flow $1,603 $2,867 -$1,701 -$2,790 -$2,740 -$4,759 -$1,815 -$2,651 -$3,101 -$3,594 -$17,058 $2,245 6.29% <-IRR #YR-> 10 5 Yr Running Average US$
Total Accruals -$2,618 -$2,527 $1,524 $1,532 $1,031 $3,727 $1,170 $1,798 $1,685 $1,700 $14,831 -$3,925 4.08% <-IRR #YR-> 5 5 Yr Running Average US$
Total Assets $16,617 $19,665 $19,512 $22,198 $23,605 $28,090 $30,424 $33,083 $34,841 $37,943 $106,685 $99,782 Balance Sheet Assets US$
Accruals Ratio -15.76% -12.85% 7.81% 6.90% 4.37% 13.27% 3.85% 5.43% 4.84% 4.48% 13.90% -3.93% 4.84% <-Median-> 5 Ratio US$
EPS/CF Ratio 0.64 1.09 0.92 0.63 0.56 0.74 0.82 0.79 0.70 0.61 0.70 0.66 0.70 <-Median-> 10 EPS/CF Ratio US$
-$2,547 $0 $0 $0 $0 $0 $0 $0 $0 $0 $3,538
-$3,096 $0 $0 $0 $0 $3,538
-$1,779 $0 $0 $0 $0 $0 $0 $0 $0 $0 $3,272
-$2,679 $0 $0 $0 $0 $3,272
Chge in Close 4.88% -5.33% 6.09% -6.63% -35.25% 36.53% -4.19% -8.74% 22.20% 26.01% 26.57% 6.31% 6.01% 0.00% 0.00% Count 22 Years of data
up/down/neutral up up up down down down down down Count 13
Any Predictions? yes yes yes yes yes % right Count 6 46.15%
Financial Cash Flow -$489 $1,316 -$3,011 -$835 -$845 $764 -$2,006 -$1,882 -$2,101 -$918 $16 -$9,543 C F Statement Financial Cash Flow US$
Total Accruals -$2,130 -$3,844 $4,535 $2,367 $1,876 $2,963 $3,176 $3,680 $3,786 $2,618 $14,815 $5,618 Accruals US$
Accruals Ratio -12.82% -19.55% 23.24% 10.66% 7.95% 10.55% 10.44% 11.12% 10.87% 6.90% 13.89% 5.63% 10.87% <-Median-> 5 Ratio US$
Cash $1,256 $1,060 $1,271 $1,400 $1,382 $1,248 $860 $1,403 $4,843 $2,876 $3,060 Cash US$
Cash per Share $1.10 $0.94 $1.14 $1.28 $1.29 $1.20 $0.85 $1.40 $3.41 $2.06 $2.19 $1.40 <-Median-> 5 Cash per Share US$
Percentage of Stock Price 2.08% 1.91% 3.55% 2.92% 3.09% 3.15% 1.81% 2.39% 4.58% 2.60% 2.61% 2.60% <-Median-> 5 % of Stock Price US$
October 22, 2016. Last estimates were for 2016, 2017 and 2018 of 28952M, $30071M and $31492M, $3.23, $3.90 and $4.38, $5.01, $5.01, $5.94 and $6.90 and $4.860, $5892 and $6.264 for Net Income.
October 22, 2015. Last estimates were for 2015, 2016 and 2017 of $17754M, $18494M and $19576M for Revenue, $3.98, $4.34 and $4.68 for EPS, $4.53, $5.20 and $5.65 CFPS
and $3794M, $4354M and $4623M for Net Income.
October 3, 2014. Last estimates were for 2014, 2015 and 2016 of $16315M, 16938M and $17488M for Revenue, $3.69, 3.82 and $4.10 for EPS, $4.43, $4.98 and $4.72 for CFPS.
September 27, 2013. Last estimates were for 2013 and 2014 of $16439M and $16943M for Revenue, $3.65 and $3.85 (and $4.12 2015) for EPS.
August 4, 2012. Last estimates were for 2011 and 2012 at $3.40 and $3.63 US$ for EPS.
Feb 18, 2011. When I last looked at this stock I got 2010 and 2011 estimates of $3.18 and $3.42 for earnings.
Jun 5, 2009 AR 2008. I would not have made any money if I had invested in this stock, from 2005 to the present. I do not think American's would have either. Dividend is very low
and this stock is way above the Graham Price. Not a stock I want.
Company was foundin in Minneapolis in 1949.
Name was changed from Medtronic Inc to Medtronic PLC in January 2015.
Company announed in June 2014 it was moving its head office to Ireland.
Would I buy this company and Why.
This is a dividend growth stock. If I was looking for a US stock, especially one in health care I would consider this stock.
Dividends
Dividends are paid quarterly using cycle July, October, January and April. Dividends are declared for shareholders of record in on month and paid in that month.
For example, the dividend declared for shareholders of record of April 5, 2013 was paid on April 26, 2013.
Why am I following this stock.
In 2009 I was looking for a good US stock for my US$ account. I had heard good things about this stock and also it is in Health Care sector which is a weak sector in Canada.
This is one of the few US stocks that I follow.
How they make their money.
Medtronic is the world's leading medical technology company, pioneering device-based therapies that restore health, extend life and alleviate pain. Primary products include those for bradycardia pacing,
tachyarrhythmia management, atrial fibrillation management, among others. Medtronic operates its business in one reportable segment, that of manufacturing and selling device-based medical therapies.
The company does business in more than 120 countries. The company's product lines include cardiac rhythm management, neurological and spinal, vascular and cardiac surgery.
For most ratios, lower is better when looking for a good stock price. However, there are exceptions such as for yield and asset/liability ratios and here you want a higher ratios to indicate a good stock price.
Also, for the Operational Profit Margin, a higher percentage is better. With the OPM, you should only compare companies in similar industries.
Shares; '%, Value $M Shares %, Val $M Shares %, Val $M Shares %, Val $M Shares %, Val $M Shares %, Val $M
Date Aug 13 2012 Sep 13 2013 Oct 3 2014 Oct 22 2015 Oct 22 2016
Ishrak Omar 0.648 0.05% 0.527 0.04% 0.566 0.04%
Chairman & CEO - Shares - Amount $46.806 $40.523 $47.486
Options - percentage 0.000 0.00% 0.000 0.00% 0.000 0.00%
Options - amount $0.000 $0.000 $0.000
Parkhill, Karen L. 0.064 0.00%
CFO - Shares - Amount $5.353
Options - percentage 0.000 0.00%
Options - amount $0.000
Ellis, Gary Lee 0.209 0.01% 0.187 0.01% 0.203 0.01% Was CFO
Officer - Shares - Amount $15.122 $14.373 $17.062
Options - percentage 0.000 0.00% 0.000 0.00% 0.000 0.00%
Options - amount $0.000 $0.000 $0.000
Coyle Michael J 0.098 0.01% 0.093 0.01% 0.150 0.01%
Officer - Shares - Amount $7.045 $7.155 $12.572
Options - percentage 0.000 0.00% 0.000 0.00% 0.000 0.00%
Options - amount $0.000 $0.000 $0.000
Anderson Richard H 0.053 0.00% 0.060 0.00% 0.072 0.01%
Director - Shares - Amount $3.800 $4.642 $6.004
Options - percentage 0.000 0.00% 0.000 0.00% 0.000 0.00%
Options - amount $0.000 $0.000 $0.000
Chairman - See above CEO
Increase in O/S Shares 4.000 0.40% 10.000 1.00% 31.000 3.10% 17.000 1.20% 15.000 1.07% Stock and EPSS
due to SO $153 $410 $1,779.090 $1,227.400 $1,153.800
Book Value $96 $267 $1,304.000 $1,088.000 $491.000
Insider Buying $0.000 $0.000
Insider Selling $8.732 $17.429
Net Insider Selling $0.000 $0.000 $1.182 $8.732 $17.429
% of Market Cap 0.00% 0.00% 0.001% 0.008% 0.01%
Directors 10 13 13
Women 3 30% 4 31% 4 31%
Minorities 2 20% 2 15% 2 15%
Institutions/Holdings 2,015 78.45% 1,446 0.00% 1,360 83.05% 1,382 85.10%
Total Shares Held 804.110 79.14% 1,268.194 89.21% 1,174.974 83.99% 1,176.006 84.06%
Increase/Decrease -8.523 -1.0% 6.978 0.6% -0.478 0.0% 9.977 0.9%
Starting No. of Shares 812.633 1,261.216 1,175.452 Nasdaq 1,166.029 Nasdaq
Copyright 2008 Website of SPBrunner. All rights reserved.